Evonik’s Business Lines Personal Care and Household Care from the Consumer Specialties Business presented their latest innovations at the SEPAWA association's congress in Fulda.
From 23rd to 25th October 2012 Evonik's Personal Care and Household Care Business Lines participated at the SEPAWA congress, along with 187 other exhibitors. More than 1,923 visitors from 40 countries came to Fulda to obtain information on new products and to listen to many presentations about new developments and ingredients.
Evonik's Personal Care Business Line presented TEGO® Stemlastin and TEGO® Cistus. Two new active ingredients that are able to fulfil todays sophisticated needs for anti-aging products. Both natural based active ingredients deliver proven efficacy, together with a high level of scientific claim substantiation, in maintaining a youthful skin appearance. TEGO® Cistus is a standardized plant extract highly enriched in polyphenols from the pink rock rose, which provides protection against sunburn cells and DNA damage. TEGO® Stemlastin is a standardized micro algae extract of a particular red algae, which shows a combined activity on epidermal stem cells and elastic fibers.
In addition two presentations were given by Evonik's Personal Care Business Line. Dr. Peter Schwab, Head of IM Cosmetic Ingredients, gave a lecture about Premium Hair Conditioning and Lasting Protection by Means of Silicone Quaternium-22 microemulsion and Polysilicone-19. In this he described how the combination of Silicone Quaternium-22 microemulsion (ABIL® ME 45) and Polysilicone-19 (ABIL® UV Quat 50) gives rise to both comprehensive color protection and premium hair conditioning, affording hair care formulations with both visible and tangible benefits for consumers. Evonik's new Silicone Quaternium-22 microemulsion is a very easy to use, multi-benefit silicone conditioning agent. The product is PEG- and preservative-free and gives excellent and intensive conditioning, which leads to extraordinary manageability and smoothness of hair, reviving even strongly damaged hair.
The second presentation was given by Dr. Matthias Mentel, R&D Manager Innovation Management Active Ingredients, who talked about Active ingredients for mature skin. Two of the latest developments from the world of Evonik Skin Care Science, the multi-lamellar concentrate SKINMIMICS® and the versatile skin vitalizer TEGO® Arjuna S with its broad activity profile, were presented as perfectly suited ingredients to combat the signs and effects of mature and, in particular, postmenopausal skin.
Evonik's Business Line Household Care focussed during this year's SEPAWA congress on two new products. The first one is the environmentally friendly biocide REWOCID® WK 30.This product is readily biodegradable, shows very low corrosion on metal surfaces and hardly leaves any residues after rinsing off with water. REWOCID® WK 30 is ideally suited for disinfection in hospitals and in veterinary practice, in production areas of food and feed products and in animal farms as well as in big kitchens. Technical Service Manager Michael Fender gave a paper about this highly interesting product in the "Forum for News".
The second product, REWOCARE® BDS 15, proved to be very popular and generated real excitement at the congress. Anika Trosin gave a lecture about the thrilling properties of this unique and fully biodegradable silicone surfactant. Due to its fantastic wetting and spreading properties, especially on non-polar surfaces, REWOCARE® BDS 15 ensures a super-fast drying effect without leaving streaks or stripes on the treated surfaces. In addition REWOCARE® BDS 15 provides an extremely low surface tension, even when combined with other surfactants, which cannot be reached with any typical oleochemical surfactant.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.